Back to search
FDAFDA · Food and drugs·Recall number Z-0730-2014

Palacos® R+G Radioplaque Bone Cement 1 x 40 g Single (with Gentamicin), 40.8 g Methyl Acrylate Copolymer, 20 ml Methyl Methacrylate Monomer 0.5 g Gentamicin, Distributed by Zimmer Dover, OH 44522 The cement is indicated for use in the second stage of a two stage revision for total joint arthroplasty after the initial infection has been cleared.

Published January 22, 2014 · Recall initiated: November 4, 2013

Summary

FDA records medical device Class II recall Z-0730-2014, published January 22, 2014 and initiated November 4, 2013. Recalling firm: Zimmer, Inc.; Status: Terminated; Reported quantity: 1,534 units; Lot: Cat No. 00-1113-140-01; lot 75974340. Class II means possible temporary or medically reversible effects, or a remote probability of serious health consequences.

Status when published: Terminated — openFDA updates weekly, so this field may not reflect the current status. Always confirm with the official notice.

What's the hazard

The patient label associated with the product may be incorrect in that the lot number on the patient label may be different than the lot number on the outer carton label.

What to do

Voluntary: Firm initiated · Letter

Get an email when a new FDA recall like this is published

Free. We only write when there's a new recall that matches. Unsubscribe in one click.

Recall details

Manufacturer
Zimmer, Inc.
Distributor
Nationwide Distribution including AZ, CA, CO, CT, FL, GA, HI, IA, ID, IL, IN, KS, KY, LA, MA, ME, MI, MN, MO, NC, NJ, NV, NY, OH, OK, OR, PA, TN, TX, UT, VA, VT, WA, WI, WV & WY.
Lot
Cat No. 00-1113-140-01; lot 75974340
Risk classification
Class II
Area (FDA)
device
Country
United States

Related recalls

Questions about this recall

Was Palacos® R+G Radioplaque Bone Cement 1 x 40 g Single (with Gentamicin), 40.8 g Methyl Acrylate Copolymer, 20 ml Methyl Methacrylate Monomer 0.5 g Gentamicin, Distributed by Zimmer Dover, OH 44522 The cement is indicated for use in the second stage of a two stage revision for total joint arthroplasty after the initial infection has been cleared. recalled?

Yes. FDA published recall Z-0730-2014 on January 22, 2014. Reported hazard: The patient label associated with the product may be incorrect in that the lot number on the patient label may be different than the lot number on the outer carton label.

What should I do if I have this product?

Voluntary: Firm initiated · Letter